An announcement from Labcorp Holdings ( (LH) ) is now available.
On April 10, 2025, Labcorp Holdings Inc. announced that its Board of Directors declared a cash dividend of $0.72 per share of common stock, payable on June 11, 2025, to stockholders of record as of May 29, 2025. This decision underscores Labcorp’s commitment to returning value to its shareholders and reflects its stable financial position, potentially enhancing its attractiveness to investors.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings shows strong financial stability with robust cash flow and moderate revenue growth. Positive earnings call guidance and technical indicators support a favorable outlook. However, premium valuation and potential margin pressures warrant caution. The overall score reflects a stable but cautiously optimistic view of Labcorp’s stock potential.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities. The company supports doctors, hospitals, pharmaceutical companies, researchers, and patients in making informed decisions, serving clients in approximately 100 countries. Labcorp’s nearly 70,000 employees contributed to 75% of the new drugs and therapeutic products approved by the FDA in 2024 and performed over 700 million tests annually worldwide.
YTD Price Performance: 0.80%
Average Trading Volume: 674,811
Technical Sentiment Signal: Buy
Current Market Cap: $19.28B
See more data about LH stock on TipRanks’ Stock Analysis page.